Table 3.
The effects of sucrose, sucralose and stevia administration on serum levels of liver and kidney functions parameters, oxidative stress biomarkers and lipid profile in male and female albino mice.
| Parameters |
Control groups |
Sucrose |
Sucralose |
Stevia |
|||||
|---|---|---|---|---|---|---|---|---|---|
| Group I | Group II | Group III | Group IV | Group V | Group VI | Group VII | Group VIII | ||
| Male mice | ALT (U/L) | 35.81 ± 6.36a | 36.42 ± 6.6a | 45.41 ± 6.79b | 47.10 ± 7.2b | 54.24 ± 2.3c | 56.38 ± 1.9c | 48.44 ± 9.5b | 57.14 ± 3.6c |
| AST (U/L) | 21.76 ± 6.5a | 20.63 ± 4.5a | 37.98 ± 5.6b | 39.18 ± 6.2b | 53.22 ± 21.6 cd | 49.18 ± 0.4c | 47.21 ± 2.7c | 61.92 ± 1.6e | |
| Urea (mg/dl) | 41.68 ± 5.7a | 42.03 ± 0.8a | 43.96 ± 4.0a | 43.01 ± 4.1a | 56.3 ± 14.9b | 57.34 ± 3.6b | 55.52 ± 9.8b | 53.32 ± 4.8b | |
| Creatinine (mg/dl) | 0.90 ± 1.43a | 1.03 ± 4.3a | 1.18 ± 0.08a | 1.20 ± 0.1a | 1.91 ± 0.4ab | 2.60 ± 6.5b | 1.81 ± 0.3ab | 2.12 ± 7.1b | |
| NO (umol/L) | 28.01 ± 1.16a | 28.21 ± 6.1a | 27.88 ± 4.2a | 29.44 ± 3.5a | 30.12 ± 1.1a | 55.82 ± 3.7b | 28.16 ± 6.9a | 58.3 ± 5.6b | |
| SOD (U/L) | 97.80 ± 1.16d | 96.85 ± 5.4d | 96.19 ± 2.5d | 93.24 ± 5.3d | 65.46 ± 1.5c | 45.18 ± 1.6a | 71.61 ± 3.3c | 56.11 ± 2.7b | |
| Chol (mg/dl) | 120.61 ± 18.73a | 121.52 ± 8.4.a | 150.84 ± 13.1b | 149.14 ± 1.3b | 159.56 ± 54.3c | 168.74 ± 10.7d | 151.34 ± 35.2b | 166.90 ± 16d | |
| TG (mg/dl) | 127.21 ± 13.6a | 126.08 ± 8.6a | 130.51 ± 10.5a | 130.91 ± 1.4a | 128.44 ± 38.8a | 130.30 ± 25.9a | 120.96 ± 25.4a | 126.74 ± 13a | |
| HDL (mg/dl) | 50.64 ± 10.26c | 49.85 ± 6.7c | 44.81 ± 6.8c | 42.46 ± 5.2b | 50.51 ± 6.7c | 36.26 ± 5.5a | 49.92 ± 6.8c | 43.84 ± 7.4b | |
| LDL (mg/dl) | 42.55 ± 5.79a | 42.01 ± 7.5a | 44.72 ± 11.5a | 46.11 ± 2.3a | 46.98 ± 40.8a | 59.43 ± 6.4b | 49.83 ± 29.3a | 62.71 ± 10b | |
| FFAs (mmol/L) | 0.62 ± 0.1a | 0.64 ± 0.2a | 0.59 ± 0.4a | 0.60 ± 0.9a | 0.94 ± 0.1b | 1.01 ± 0.5b | 0.86 ± 0.3b | 0.9 ± 0.6b | |
| Liver TG (mg/g) | 105.16 ± 0.65a | 103.44 ± 0.4a | 102.41 ± 1.3a | 103.21 ± 3.1a | 100.78 ± 0.8a | 101.36 ± 2.7a | 108.67 ± 0.5a | 102.77 ± 6.7a | |
| Liver Chol (mg/g) | 87.13 ± 4.03a | 89.46 ± 0.6a | 95.77 ± 2.4b | 100.41 ± 1.1b | 101.49 ± 5.2b | 121.77 ± 9.2c | 105.11 ± 2.9b | 130.43 ± 11.4c | |
| Female mice | ALT (U/L) | 32.22 ± 3.6a | 33.20 ± 7.6a | 36.32 ± 7.9a | 39.92 ± 5.1a | 54.24 ± 23.3c | 56.38 ± 1.9c | 48.44 ± 9.1b | 56.14 ± 2.6c |
| AST (U/L) | 25.62 ± 2.5a | 26.55 ± 19.4a | 29.30 ± 3.2a | 31.31 ± 0.4a | 52.01 ± 5.2c | 51.34 ± 0.8c | 42.21 ± 1.6b | 49.08 ± 0.7c | |
| Urea (mg/dl) | 39.18 ± 3.6a | 38.07 ± 2.6a | 41.23 ± 0.6a | 45.34 ± 6.1ab | 49.62 ± 6.1b | 51.32 ± 2.9b | 42.61 ± 1.6a | 48.02 ± 2.8b | |
| Creatinine (mg/dl) | 0.82 ± 1.4a | 0.91 ± 7.4a | 1.01 ± 4.4a | 1.21 ± 4.6a | 2.06 ± 1.2b | 2.04 ± 0.8b | 2.71 ± 1.5c | 2.91 ± 0.4c | |
| NO (umol/L) | 37.48 ± 6.6a | 36.77 ± 4.3a | 37.03 ± 6.1a | 39.74 ± 7.6a | 39.62 ± 1.6a | 59.78 ± 3.2b | 41.31 ± 1.6a | 55.32 ± 3.1b | |
| SOD (U/L) | 112.14 ± 1.1d | 113.63 ± 12.4d | 106.03 ± 2.4d | 104.14 ± 7.3d | 87.14 ± 1.17b | 69.61 ± 4.1a | 91.80 ± 1.6c | 72.66 ± 2.3b | |
| Chol (mg/dl) | 100.91 ± 7.2a | 101.13 ± 4.9a | 120.22 ± 5.2b | 124.04 ± 4.9b | 95.62 ± 23.7a | 170.05 ± 8.4d | 95.21 ± 1.6a | 157.92 ± 9.3c | |
| TG (mg/dl) | 71.34 ± 7.8a | 70.03 ± 7.6a | 69.03 ± 0.4a | 70.43 ± 4.8a | 67.21 ± 16.8a | 69.92 ± 7.2a | 68.62 ± 1.6a | 69.68 ± 14.5a | |
| HDL (mg/dl) | 44.06 ± 3.1b | 43.65 ± 6.1b | 45.36 ± 1.6b | 43.61 ± 1.3b | 41.22 ± 5.9b | 33.34 ± 3.5a | 40.52 ± 1.6b | 32.41 ± 4.1a | |
| LDL (mg/dl) | 47.61 ± 2.5a | 46.97 ± 0.5a | 48.11 ± 4.8a | 49.54 ± 0.4a | 49.90 ± 14.5a | 90.48 ± 4.9b | 46.98 ± 0.3a | 85.16 ± 6.4b | |
| FFAs (mmol/L) | 0.59 ± 0.3a | 0.54 ± 0.4a | 0.56 ± 0.1a | 0.58 ± 0.6a | 0.99 ± 0.6c | 1.1 ± 0.6c | 0.73 ± 0.4b | 0.83 ± 0.2b | |
| Liver TG (mg/g) | 77.65 ± 1.1a | 75.33 ± 0.9a | 76.53 ± 4.1a | 74.69 ± 2.4a | 77.98 ± 3.1a | 71.43 ± 0.8a | 77.44 ± 3.4a | 78.56 ± 6.1a | |
| Liver Chol (mg/g) | 55.43 ± 2.0a | 58.96 ± 0.4a | 56.47 ± 3.2a | 59.41 ± 2.3a | 77.23 ± 0.9b | 94.33 ± 1.3c | 81.42 ± 1.9b | 110.74 ± 7.1d | |
Data were presented as mean ± SD. Means followed by the same letter within the same row were not significantly different (P > 0.05), whereas those marked with different ones were significantly differed (P < 0.05) using analysis of variance [ANOVA]; Duncan's Multiple Range test (DMRT). Group I and II: Control groups receiving normal drinking water without sweeteners for 8 and 16 weeks, Group III: Mice received sucrose for 8 weeks, group IV: Mice received sucrose for 16 weeks, group V: Mice received sucralose for 8 weeks, Group VI: Mice received sucralose for 16 weeks, Group VII: Mice received stevia for 8 weeks, Group VIII: Mice received stevia for 16 weeks.